RSS-Feed abonnieren
DOI: 10.1055/s-0038-1660141
Influence of β2-Glycoprotein-l Upon the Content of cAMP and cGMP in Human Blood Platelets
Publikationsverlauf
Received 03. Juni 1985
Accepted 17. September 1985
Publikationsdatum:
19. Juli 2018 (online)
![](https://www.thieme-connect.de/media/10.1055-s-00035024/198504/lookinside/thumbnails/10-1055-s-0038-1660141-1.jpg)
Summary
The influence of β2-glycoprotein-I on the cyclic nucleotide content in human gel filtered platelets (GFP) was studied: 1) β2-G-I up to a concentration of 5 mg/ml does not alter the basal cAMP level in resting GFP and also does not influence the action of PGE1 which strongly inhibits platelet aggregation by elevation of cAMP.
2) Collagen induced aggregation of GFP leads to an increase of the platelet cGMP content. Preincubation of GFP with 0.2 mg/ml of β2-G-I enhances significantly the cGMP increase by collagen.
3) In a similar manner β2-G-I also amplifies the increase in cGMP concentration induced by ADP. In this case, a concomitant alteration of the aggregation pattern is observed.
4) Thrombin produces a much higher cGMP elevation in GFP than ADP or collagen. The admixture of 0.2 mg/ml of β2-G-I is not able to enhance further the thrombin effect on cGMP. The results are discussed in view of the possible significance of these observations for platelet aggregation in vivo.
-
References
- 1 Schultze HE, Heide K, Haupt H. Uber ein bisher unbekanntes niedermolekulares β2-Globulin des Humanserums. Naturwissenschaf-ten 1961; 23: 719
- 2 Polz E, Kostner GM. The binding of β2-glycoprotein-I to human serum lipoproteins. FEBS Lett 1979; 102: 183-186
- 3 Polz E, Kostner GM. Binding of (β2-glycoprotein-I to Intralipid: Determination of the dissociation constant. Biochem Biophys Res Commun 1979; 90: 1305-1312
- 4 Nakaya Y, Schaefer EJ, Brewer HB. Activation of human post heparin lipase by apolipoprotein H (β2-glycoprotein-I). Biochem Biophys Res Commun 1980; 95: 1168-1172
- 5 Wurm H, Beubler E, Polz E, Holasek A, Kostner GM. Studies on the possible function of β2-glycoprotein-I: Influence in the triglyceride metabolism in the rat. Metabolism 1982; 31: 484-486
- 6 Wurm H. β2-glycoprotein-I (apolipoprotein-H) interactions with phospholipid vesicles. Int J Biochem 1984; 16: 511-517
- 7 Schousboe I. Binding of β2-glycoprotein-I to platelets: Effect of adenylate cyclase activity. Thromb Res 1980; 19: 225-237
- 8 Schousboe I. Effect of β2-glycoprotein-I on the activity of adenylate cyclase in platelet membranes. Thromb Res 1983; 32: 291-299
- 9 Haslam RJ, Davidson M ML, Davies T, Lynham JA, McClenaghan MD. Regulation of blood platelet function by cyclic nucleotides. Adv Cycl Nucl Res 1978; 9: 533-588
- 10 Haslam RJ. Roles of cyclic nucleotides in platelet function. In Ciba Geigy Foundation Symposium. Elsevier, Amsterdam 1975; 35: 121-151
- 11 Mills D CB, Smith JB. The influence on platelet aggregation of drugs that affect the accumulation of adenosine 3’:5’-cyclic monophosphate in platelets. Biochem J 1971; 121: 185-196
- 12 Best LC, Martin TJ, Russell R GG, Preston FE. Prostacyclin increases cyclic AMP levels and adenylate cyclase activity in platelets. Nature 1977; 267: 850-851
- 13 Nimpf J, Wurm H, Kostner GM. Interaction of β2-glycoprotein-I with human blood platelets: Influence upon the ADP-induced aggregation. Thromb Haemostas 1985; 54: 397-401
- 14 Born G VR. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 1962; 194: 927-929
- 15 Graber SE, Hawiger J. Evidence that changes in platelet cyclic AMP levels regulate the fibrinogen receptor on human platelets. J Biol Chem 1982; 257: 14606-14609
- 16 Schultz KD, Schultz K, Schultz G. Sodium nitroprusside and other smooth muscle-relaxants increase cyclic GMP levels in rat ductus deferens. Nature 1977; 265: 750-751